Trial Profile
Double treatment with paricalcitol-associated calcifediol and cardiovascular risk biomarkers in haemodialysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary) ; Calcifediol
- Indications Secondary hyperparathyroidism
- Focus Biomarker; Therapeutic Use
- 14 Dec 2015 New trial record